Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant largest » significantly larger (Expand Search), significant changes (Expand Search), significant dangers (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant largest » significantly larger (Expand Search), significant changes (Expand Search), significant dangers (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
-
1981
-
1982
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
1983
-
1984
-
1985
-
1986
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
1987
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
1988
-
1989
-
1990
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
1991
-
1992
-
1993
-
1994
-
1995
-
1996
-
1997
-
1998
-
1999
Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.
Published 2025Subjects: -
2000